New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Simple item page
dc.contributor.authorFaustino Torrico
dc.contributor.authorJoaquím Gascón
dc.contributor.authorFabiana Barreira
dc.contributor.authorBethania Blum
dc.contributor.authorIgor C. Almeida
dc.contributor.authorCristina Alonso‐Vega
dc.contributor.authorTayná Barboza
dc.contributor.authorGraeme Bilbe
dc.contributor.authorErika Correia
dc.contributor.authorWilson García
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:51:53Z
dc.date.available2026-03-22T13:51:53Z
dc.date.issued2021
dc.descriptionCitaciones: 195
dc.description.abstractFor the Spanish translation of the abstract see Supplementary Materials section.
dc.identifier.doi10.1016/s1473-3099(20)30844-6
dc.identifier.urihttps://doi.org/10.1016/s1473-3099(20)30844-6
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43166
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofThe Lancet Infectious Diseases
dc.sourceUniversity of San Simón
dc.subjectBenznidazole
dc.subjectMedicine
dc.subjectDiscontinuation
dc.subjectTolerability
dc.subjectInternal medicine
dc.subjectAdverse effect
dc.subjectPopulation
dc.subjectPlacebo
dc.titleNew regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
dc.typearticle

Files

Collections

Artículo Científico Publicado